$XCUR
Exicure Inc Stock $xcur

$xcur Overview Financials Valuation SEC Filings Company Website

2018 Q4 Form 10-Q Financial Statement

#000169853018000089 Filed on November 06, 2018

Income Statement

Concept	2018 Q4	2018 Q3	2017 Q4
Revenue	$6.000K	$57.00K	$2.095M
YoY Change	-99.71%	-97.72%	203.62%
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin	$1.870M	$1.920M	$2.240M
YoY Change	-16.52%	51.18%	180.0%
% of Gross Profit
Research & Development	$3.010M	$4.001M	$2.830M
YoY Change	6.36%	28.2%	-46.9%
% of Gross Profit
Depreciation & Amortization	$90.00K	$90.00K	$70.00K
YoY Change	28.57%	28.57%	40.0%
% of Gross Profit
Operating Expenses	$4.870M	$5.920M	$5.070M
YoY Change	-3.94%	34.82%	-17.29%
Operating Profit		-$5.863M
YoY Change		209.56%
Interest Expense	-$180.0K	$170.0K	-$180.0K
YoY Change	0.0%	-15.42%	-14.29%
% of Operating Profit
Other Income/Expense, Net	$290.0K	$539.0K	$50.00K
YoY Change	480.0%	-1518.42%	400.0%
Pretax Income	-$4.760M	-$5.320M	-$3.100M
YoY Change	53.55%	175.65%	-45.04%
Income Tax	$0.00	$0.00	$0.00
% Of Pretax Income
Net Earnings	-$4.755M	-$5.324M	-$3.443M
YoY Change	38.11%	175.57%	-38.95%
Net Earnings / Revenue	-79250.0%	-9340.35%	-164.34%
Basic Earnings Per Share
Diluted Earnings Per Share	-$107.2K	-$128.1K	-$78.88K
COMMON SHARES
Basic Shares Outstanding	44.36M shares	39.45M shares	39.30M shares
Diluted Shares Outstanding

Balance Sheet

Concept	2018 Q4	2018 Q3	2017 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments	$26.30M	$32.40M	$25.80M
YoY Change	1.94%	41.48%
Cash & Equivalents	$26.27M	$32.45M	$25.76M
Short-Term Investments
Other Short-Term Assets	$1.400M	$1.900M	$1.800M
YoY Change	-22.22%	72.73%
Inventory
Prepaid Expenses	$293.0K
Receivables	$0.00	$52.00K	$0.00
Other Receivables	$0.00	$0.00	$0.00
Total Short-Term Assets	$27.66M	$34.36M	$27.64M
YoY Change	0.09%	41.53%	37.91%
LONG-TERM ASSETS
Property, Plant & Equipment	$1.061M	$1.130M	$1.317M
YoY Change	-19.44%	6.7%	161.83%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets	$32.00K	$32.00K	$32.00K
YoY Change	0.0%	0.0%	0.0%
Total Long-Term Assets	$1.093M	$1.162M	$1.349M
YoY Change	-18.98%	6.51%	152.15%
TOTAL ASSETS
Total Short-Term Assets	$27.66M	$34.36M	$27.64M
Total Long-Term Assets	$1.093M	$1.162M	$1.349M
Total Assets	$28.76M	$35.53M	$28.99M
YoY Change	-0.8%	40.03%	40.88%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$500.0K	$1.341M	$1.049M
YoY Change	-52.34%	-43.63%	106.09%
Accrued Expenses	$1.543M	$3.035M	$1.273M
YoY Change	21.21%	21.59%	-41.06%
Deferred Revenue	$0.00	$0.00	$1.034M
YoY Change	-100.0%
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due	$0.00	$4.926M	$0.00
YoY Change		93.1%	-100.0%
Total Short-Term Liabilities	$2.043M	$9.302M	$3.356M
YoY Change	-39.12%	-11.65%	-72.4%
LONG-TERM LIABILITIES
Long-Term Debt	$4.925M	$0.00	$4.855M
YoY Change	1.44%	-100.0%	9.0%
Other Long-Term Liabilities	$39.00K	$42.00K	$278.0K
YoY Change	-85.97%	-84.95%	-1.07%
Total Long-Term Liabilities	$4.964M	$42.00K	$5.133M
YoY Change	-3.29%	-98.58%	8.41%
TOTAL LIABILITIES
Total Short-Term Liabilities	$2.043M	$9.302M	$3.356M
Total Long-Term Liabilities	$4.964M	$42.00K	$5.133M
Total Liabilities	$7.804M	$10.33M	$9.012M
YoY Change	-13.4%	-24.55%	-50.29%
SHAREHOLDERS EQUITY
Retained Earnings	-$54.99M	-$50.24M	-$33.62M
YoY Change	63.6%	59.28%	48.71%
Common Stock	$4.000K	$4.000K	$4.000K
YoY Change	0.0%	0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$20.95M	$25.20M	$19.98M
YoY Change
Total Liabilities & Shareholders Equity	$28.76M	$35.53M	$28.99M
YoY Change	-0.8%	40.03%	40.88%

Cashflow Statement

Concept	2018 Q4	2018 Q3	2017 Q4
OPERATING ACTIVITIES
Net Income	-$4.755M	-$5.324M	-$3.443M
YoY Change	38.11%	175.57%	-38.95%
Depreciation, Depletion And Amortization	$90.00K	$90.00K	$70.00K
YoY Change	28.57%	28.57%	40.0%
Cash From Operating Activities	-$5.970M	-$4.190M	-$5.340M
YoY Change	11.8%	4.75%	-194.85%
INVESTING ACTIVITIES
Capital Expenditures	-$20.00K	-$10.00K	-$200.0K
YoY Change	-90.0%	-97.06%	185.71%
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities	-$20.00K	-$10.00K	-$200.0K
YoY Change	-90.0%	-97.06%	185.71%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-180.0K	20.26M	8.370M
YoY Change	-102.15%	9.81%	83600.0%
NET CHANGE
Cash From Operating Activities	-5.970M	-4.190M	-5.340M
Cash From Investing Activities	-20.00K	-10.00K	-200.0K
Cash From Financing Activities	-180.0K	20.26M	8.370M
Net Change In Cash	-6.170M	16.06M	2.830M
YoY Change	-318.02%	13.82%	-49.19%
FREE CASH FLOW
Cash From Operating Activities	-$5.970M	-$4.190M	-$5.340M
Capital Expenditures	-$20.00K	-$10.00K	-$200.0K
Free Cash Flow	-$5.950M	-$4.180M	-$5.140M
YoY Change	15.76%	14.21%	-190.18%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
	dei	Amendment Flag AmendmentFlag	false
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q3
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2018
	dei	Document Period End Date DocumentPeriodEndDate	2018-09-30
	dei	Document Type DocumentType	10-Q
	dei	Entity Central Index Key EntityCentralIndexKey	0001698530
CY2018Q4	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	44358000	shares
	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	true
	dei	Entity Ex Transition Period EntityExTransitionPeriod	true
	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
	dei	Entity Registrant Name EntityRegistrantName	EXICURE, INC.
	dei	Entity Small Business EntitySmallBusiness	true
CY2017Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	1049000	USD
CY2018Q3	us-gaap	Accounts Payable Current AccountsPayableCurrent	1341000	USD
CY2017Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	0	USD
CY2018Q3	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	52000	USD
CY2017Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	1273000	USD
CY2018Q3	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	3035000	USD
CY2017Q4	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	251000	USD
CY2018Q3	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	1068000	USD
CY2012Q1	us-gaap	Accrued Rent Current And Noncurrent AccruedRentCurrentAndNoncurrent	52000	USD
CY2017Q4	us-gaap	Accrued Rent Current And Noncurrent AccruedRentCurrentAndNoncurrent	48000	USD
CY2018Q3	us-gaap	Accrued Rent Current And Noncurrent AccruedRentCurrentAndNoncurrent	41000	USD
CY2017Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	849000	USD
CY2018Q3	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	1097000	USD
CY2017Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	53586000	USD
CY2018Q3	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	75433000	USD
	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	1300000	USD
CY2017Q3	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	362000	USD
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	1104000	USD
CY2018Q3	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	516000	USD
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	1300000	USD
	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	150000	USD
	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	71000	USD
CY2017Q4	us-gaap	Assets Assets	28987000	USD
CY2018Q3	us-gaap	Assets Assets	35526000	USD
CY2017Q4	us-gaap	Assets Current AssetsCurrent	27638000	USD
CY2018Q3	us-gaap	Assets Current AssetsCurrent	34364000	USD
	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	0	USD
	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	14000	USD
CY2016Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	19623000	USD
CY2017Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	22936000	USD
CY2017Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	25764000	USD
CY2018Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	32446000	USD
	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	3313000	USD
	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	6682000	USD
CY2017Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2018Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2017Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	200000000	shares
CY2018Q3	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	200000000	shares
CY2017Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	39300823	shares
CY2018Q3	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	44358000	shares
CY2017Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	39300823	shares
CY2018Q3	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	44358000	shares
CY2017Q4	us-gaap	Common Stock Value CommonStockValue	4000	USD
CY2018Q3	us-gaap	Common Stock Value CommonStockValue	4000	USD
CY2017Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	1034000	USD
CY2018Q3	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	0	USD
CY2017Q4	us-gaap	Cumulative Effect Of New Accounting Principle In Period Of Adoption CumulativeEffectOfNewAccountingPrincipleInPeriodOfAdoption	1034000	USD
CY2018Q3	us-gaap	Debt Instrument Carrying Amount DebtInstrumentCarryingAmount	4999000	USD
CY2018Q3	us-gaap	Debt Instrument Unamortized Discount DebtInstrumentUnamortizedDiscount	65000	USD
CY2018Q3	us-gaap	Deferred Finance Costs Net DeferredFinanceCostsNet	8000	USD
CY2017Q3	us-gaap	Depreciation Amortization And Accretion Net DepreciationAmortizationAndAccretionNet	70000	USD
	us-gaap	Depreciation Amortization And Accretion Net DepreciationAmortizationAndAccretionNet	159000	USD
CY2018Q3	us-gaap	Depreciation Amortization And Accretion Net DepreciationAmortizationAndAccretionNet	90000	USD
	us-gaap	Depreciation Amortization And Accretion Net DepreciationAmortizationAndAccretionNet	266000	USD
CY2017Q4	us-gaap	Due From Related Parties Current DueFromRelatedPartiesCurrent	17000	USD
CY2018Q3	us-gaap	Due From Related Parties Current DueFromRelatedPartiesCurrent	4000	USD
CY2017Q3	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-1.12
	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-41.27
CY2018Q3	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.13
	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.44
CY2017Q3	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.00
	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.00
CY2018Q3	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.00
	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.00
CY2017Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	718000	USD
CY2018Q3	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	732000	USD
CY2018Q3	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized	3635000	USD
	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1 EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1	P2Y9M
	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	-201000	USD
	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	461000	USD
CY2017Q3	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	1270000	USD
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	4806000	USD
CY2018Q3	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	1919000	USD
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	5952000	USD
CY2017Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	USD
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	USD
CY2018Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	USD
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	USD
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	1361000	USD
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	278000	USD
	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	-1209000	USD
	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	1602000	USD
	us-gaap	Increase Decrease In Contract With Customer Asset IncreaseDecreaseInContractWithCustomerAsset	201000	USD
	us-gaap	Increase Decrease In Contract With Customer Asset IncreaseDecreaseInContractWithCustomerAsset	46000	USD
	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	-6207000	USD
	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	0	USD
	us-gaap	Increase Decrease In Due From Related Parties Current IncreaseDecreaseInDueFromRelatedPartiesCurrent	-2000	USD
	us-gaap	Increase Decrease In Due From Related Parties Current IncreaseDecreaseInDueFromRelatedPartiesCurrent	-13000	USD
	us-gaap	Increase Decrease In Other Noncurrent Liabilities IncreaseDecreaseInOtherNoncurrentLiabilities	-2000	USD
	us-gaap	Increase Decrease In Other Noncurrent Liabilities IncreaseDecreaseInOtherNoncurrentLiabilities	-237000	USD
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	1835000	USD
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-135000	USD
CY2017Q3	us-gaap	Interest Expense InterestExpense	201000	USD
	us-gaap	Interest Expense InterestExpense	616000	USD
CY2018Q3	us-gaap	Interest Expense InterestExpense	170000	USD
	us-gaap	Interest Expense InterestExpense	497000	USD
CY2017Q3	us-gaap	Interest Paid Net InterestPaidNet	158000	USD
CY2018Q3	us-gaap	Interest Paid Net InterestPaidNet	146000	USD
	us-gaap	Interest Paid Net InterestPaidNet	425000	USD
	us-gaap	Interest Paid Net InterestPaidNet	470000	USD
CY2014Q1	us-gaap	Lessee Operating Lease Renewal Term LesseeOperatingLeaseRenewalTerm	P6Y
CY2017Q4	us-gaap	Liabilities Liabilities	9012000	USD
CY2018Q3	us-gaap	Liabilities Liabilities	10328000	USD
CY2017Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	28987000	USD
CY2018Q3	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	35526000	USD
CY2017Q4	us-gaap	Liabilities Current LiabilitiesCurrent	3356000	USD
CY2018Q3	us-gaap	Liabilities Current LiabilitiesCurrent	9302000	USD
CY2017Q4	us-gaap	Long Term Debt LongTermDebt	4855000	USD
CY2018Q3	us-gaap	Long Term Debt LongTermDebt	4926000	USD
CY2017Q4	us-gaap	Long Term Debt Current LongTermDebtCurrent	0	USD
CY2018Q3	us-gaap	Long Term Debt Current LongTermDebtCurrent	4926000	USD
CY2018Q3	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Two LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo	4999000	USD
CY2018Q3	us-gaap	Long Term Debt Maturities Repayments Of Principal Remainder Of Fiscal Year LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear	0	USD
CY2017Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	4855000	USD
CY2018Q3	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	0	USD
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	18486000	USD
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	20271000	USD
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-726000	USD
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-65000	USD
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-14447000	USD
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-13524000	USD
CY2017Q3	us-gaap	Net Income Loss NetIncomeLoss	-1932000	USD
	us-gaap	Net Income Loss NetIncomeLoss	-7568000	USD
CY2018Q3	us-gaap	Net Income Loss NetIncomeLoss	-5324000	USD
	us-gaap	Net Income Loss NetIncomeLoss	-17658000	USD
CY2017Q3	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-38000	USD
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-476000	USD
CY2018Q3	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	539000	USD
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-707000	USD
CY2017Q3	us-gaap	Operating Expenses OperatingExpenses	4391000	USD
	us-gaap	Operating Expenses OperatingExpenses	14716000	USD
CY2018Q3	us-gaap	Operating Expenses OperatingExpenses	5920000	USD
	us-gaap	Operating Expenses OperatingExpenses	17063000	USD
CY2017Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-1894000	USD
	us-gaap	Operating Income Loss OperatingIncomeLoss	-7092000	USD
CY2018Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-5863000	USD
	us-gaap	Operating Income Loss OperatingIncomeLoss	-16951000	USD
CY2018Q3	us-gaap	Operating Leases Future Minimum Payments Due OperatingLeasesFutureMinimumPaymentsDue	844000	USD
CY2018Q3	us-gaap	Operating Leases Future Minimum Payments Due In Four Years OperatingLeasesFutureMinimumPaymentsDueInFourYears	59000	USD
CY2018Q3	us-gaap	Operating Leases Future Minimum Payments Due In Three Years OperatingLeasesFutureMinimumPaymentsDueInThreeYears	353000	USD
CY2018Q3	us-gaap	Operating Leases Future Minimum Payments Due In Two Years OperatingLeasesFutureMinimumPaymentsDueInTwoYears	347000	USD
CY2018Q3	us-gaap	Operating Leases Future Minimum Payments Due Thereafter OperatingLeasesFutureMinimumPaymentsDueThereafter	0	USD
CY2018Q3	us-gaap	Operating Leases Future Minimum Payments Remainder Of Fiscal Year OperatingLeasesFutureMinimumPaymentsRemainderOfFiscalYear	85000	USD
CY2017Q3	us-gaap	Operating Leases Rent Expense Contingent Rentals OperatingLeasesRentExpenseContingentRentals	77000	USD
	us-gaap	Operating Leases Rent Expense Contingent Rentals OperatingLeasesRentExpenseContingentRentals	232000	USD
CY2018Q3	us-gaap	Operating Leases Rent Expense Contingent Rentals OperatingLeasesRentExpenseContingentRentals	67000	USD
	us-gaap	Operating Leases Rent Expense Contingent Rentals OperatingLeasesRentExpenseContingentRentals	231000	USD
	us-gaap	Operating Leases Rent Expense Net OperatingLeasesRentExpenseNet	481000	USD
	us-gaap	Operating Leases Rent Expense Minimum Rentals OperatingLeasesRentExpenseMinimumRentals	249000	USD
CY2017Q3	us-gaap	Operating Leases Rent Expense Net OperatingLeasesRentExpenseNet	160000	USD
CY2017Q3	us-gaap	Operating Leases Rent Expense Minimum Rentals OperatingLeasesRentExpenseMinimumRentals	83000	USD
	us-gaap	Operating Leases Rent Expense Minimum Rentals OperatingLeasesRentExpenseMinimumRentals	249000	USD
CY2018Q3	us-gaap	Operating Leases Rent Expense Minimum Rentals OperatingLeasesRentExpenseMinimumRentals	83000	USD
CY2018Q3	us-gaap	Operating Leases Rent Expense Net OperatingLeasesRentExpenseNet	150000	USD
	us-gaap	Operating Leases Rent Expense Net OperatingLeasesRentExpenseNet	480000	USD
CY2017Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	99000	USD
CY2018Q3	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	584000	USD
CY2017Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	32000	USD
CY2018Q3	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	32000	USD
CY2017Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	278000	USD
CY2018Q3	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	42000	USD
CY2017Q3	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	163000	USD
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	140000	USD
CY2018Q3	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	709000	USD
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-210000	USD
	us-gaap	Other Operating Activities Cash Flow Statement OtherOperatingActivitiesCashFlowStatement	0	USD
	us-gaap	Other Operating Activities Cash Flow Statement OtherOperatingActivitiesCashFlowStatement	291000	USD
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	726000	USD
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	65000	USD
CY2017Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2018Q3	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2017Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	10000000	shares
CY2018Q3	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	10000000	shares
CY2017Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2018Q3	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2017Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2018Q3	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2017Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	1844000	USD
CY2018Q3	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	1855000	USD
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	20302000	USD
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	22001000	USD
	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	43000	USD
	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	41000	USD
CY2017Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	2166000	USD
CY2018Q3	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	2227000	USD
CY2017Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	1317000	USD
CY2018Q3	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	1130000	USD
	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	595000	USD
	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	0	USD
CY2017Q3	us-gaap	Research And Development Arrangement Contract To Perform For Others Costs Incurred Gross ResearchAndDevelopmentArrangementContractToPerformForOthersCostsIncurredGross	428000	USD
	us-gaap	Research And Development Arrangement Contract To Perform For Others Costs Incurred Gross ResearchAndDevelopmentArrangementContractToPerformForOthersCostsIncurredGross	1417000	USD
CY2017Q3	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	3121000	USD
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	9910000	USD
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	36282	shares
CY2018Q3	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	4001000	USD
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	11111000	USD
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	1277744	shares
CY2017Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-33615000	USD
CY2017Q3	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	2497000	USD
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	7624000	USD
CY2017Q3	us-gaap	Revenues Revenues	2497000	USD
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	2.92
CY2018Q3	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-50239000	USD
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	112000	USD
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0.00
CY2018Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	3021753	shares
	us-gaap	Revenues Revenues	7624000	USD
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	2.40
CY2018Q3	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	57000	USD
CY2018Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	1.62
CY2018Q3	us-gaap	Revenues Revenues	57000	USD
	us-gaap	Revenues Revenues	112000	USD
	us-gaap	Share Based Compensation ShareBasedCompensation	1104000	USD
	us-gaap	Share Based Compensation ShareBasedCompensation	1300000	USD
CY2017Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice	4.21
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0.00
CY2017Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	3672620	shares
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue	202000	USD
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue	51000	USD
CY2018Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	4891588	shares
CY2017Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	1.79
CY2018Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	2.22
CY2018Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Aggregate Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue	9421000	USD
CY2017Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Aggregate Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue	5221000	USD
CY2018Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Aggregate Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue	9523000	USD
CY2018Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber	4778505	shares
CY2018Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice	2.20
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	1.81
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	2.29
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	3.45
CY2017Q3	us-gaap	Share Price SharePrice	4.21
CY2018Q3	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1	7541000	USD
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1	P6Y9M
CY2017	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P7Y6M
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P7Y7M18D
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1	P7Y6M
	us-gaap	Stock Issued1 StockIssued1	0	USD
	us-gaap	Stock Issued1 StockIssued1	436000	USD
CY2018Q1	us-gaap	Stock Issued During Period Shares Issued For Services StockIssuedDuringPeriodSharesIssuedForServices	145466	shares
	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	22494	shares
	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	436000	USD
	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	20070000	USD
	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	41000	USD
CY2017Q4	us-gaap	Stockholders Equity StockholdersEquity	19975000	USD
CY2018Q3	us-gaap	Stockholders Equity StockholdersEquity	25198000	USD
CY2017Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest Adjusted Balance1 StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAdjustedBalance1	21009000	USD
CY2017Q4	us-gaap	Unbilled Receivables Current UnbilledReceivablesCurrent	13000	USD
CY2018Q3	us-gaap	Unbilled Receivables Current UnbilledReceivablesCurrent	7000	USD
CY2017Q3	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	1725906	shares
	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	183395	shares
CY2018Q3	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	41527922	shares
	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	40121295	shares
CY2017Q4	xcur	Accrued Clinical Contract Research And Manufacturing Costs Current AccruedClinicalContractResearchAndManufacturingCostsCurrent	205000	USD
CY2018Q3	xcur	Accrued Clinical Contract Research And Manufacturing Costs Current AccruedClinicalContractResearchAndManufacturingCostsCurrent	651000	USD
CY2018Q3	xcur	Common Stock Voting Rightsfor Each Share CommonStockVotingRightsforEachShare	1	vote_per_share
CY2017Q4	xcur	Common Stock Warrant Liability CommonStockWarrantLiability	523000	USD
CY2018Q3	xcur	Common Stock Warrant Liability CommonStockWarrantLiability	984000	USD
	xcur	Fair Value Assumptions Impact Of10 Percent Change In Expected Volatility Rate FairValueAssumptionsImpactOf10PercentChangeInExpectedVolatilityRate	55000	USD
	xcur	Fair Value Assumptions Impact Of10 Percent Change In Fair Value Of Common Stock FairValueAssumptionsImpactOf10PercentChangeInFairValueOfCommonStock	141000	USD
	xcur	Issuance Of Common Stock Warrants IssuanceOfCommonStockWarrants	211000	USD
	xcur	Issuance Of Common Stock Warrants IssuanceOfCommonStockWarrants	0	USD
CY2018Q3	xcur	Retained Earnings Accumulated Deficit Inceptionto Date RetainedEarningsAccumulatedDeficitInceptiontoDate	-69076000	USD
	xcur	Sharebased Compensation Arrangementby Sharebased Payment Award Fair Value Assumptions Forfeiture Rate SharebasedCompensationArrangementbySharebasedPaymentAwardFairValueAssumptionsForfeitureRate	0.05
	xcur	Payments Of Common Stock Financing Costs PaymentsOfCommonStockFinancingCosts	1264000	USD
	xcur	Payments Of Common Stock Financing Costs PaymentsOfCommonStockFinancingCosts	1771000	USD
	xcur	Paymentsfor License Agreements PaymentsforLicenseAgreements	3844000	USD
	xcur	Sharebased Compensation Arrangementby Sharebased Payment Award Fair Value Assumptions Forfeiture Rate SharebasedCompensationArrangementbySharebasedPaymentAwardFairValueAssumptionsForfeitureRate	0.05
	xcur	Stock Issuance Costs Incurred During Noncashor Partial Noncash Transaction StockIssuanceCostsIncurredDuringNoncashorPartialNoncashTransaction	1773000	USD
	xcur	Stock Issuance Costs Incurred During Noncashor Partial Noncash Transaction StockIssuanceCostsIncurredDuringNoncashorPartialNoncashTransaction	160000	USD
	us-gaap	Use Of Estimates UseOfEstimates	<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-bottom:12px;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:Times New Roman;font-size:10pt;color:#000000;font-style:italic;font-weight:bold;text-decoration:none;">Use of Estimates</font></div><div style="line-height:120%;padding-bottom:12px;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:Times New Roman;font-size:10pt;color:#000000;">The preparation of the financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Management bases its estimates on certain assumptions which it believes are reasonable in the circumstance and while actual results could differ from those estimates, management does not believe that any change in those assumptions in the near term would have a significant effect on the Company’s financial position, results of operations or cash flows. Actual results in future periods could differ from those estimates.</font></div></div>

Files In Submission

Name	View Source	Status
0001698530-18-000089-index-headers.html	Edgar Link	pending
0001698530-18-000089-index.html	Edgar Link	pending
0001698530-18-000089.txt	Edgar Link	pending
0001698530-18-000089-xbrl.zip	Edgar Link	pending
exicure10q93018.htm	Edgar Link	pending
exicureexhibit311-93018.htm	Edgar Link	pending
exicureexhibit312-93018.htm	Edgar Link	pending
exicureexhibit321-93018.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
xcur-20180930.xml	Edgar Link	completed
xcur-20180930.xsd	Edgar Link	pending
xcur-20180930_cal.xml	Edgar Link	unprocessable
xcur-20180930_def.xml	Edgar Link	unprocessable
xcur-20180930_lab.xml	Edgar Link	unprocessable
xcur-20180930_pre.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$XCUR
Exicure Inc Stock $xcur

2018 Q4 Form 10-Q Financial Statement

#000169853018000089 Filed on November 06, 2018

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$XCUR Exicure Inc Stock $xcur

2018 Q4 Form 10-Q Financial Statement

#000169853018000089 Filed on November 06, 2018

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$XCUR
Exicure Inc Stock $xcur